| Literature DB >> 33918861 |
Damiano Paolicelli1, Alessia Manni1, Antonio Iaffaldano1, Giusy Tancredi1, Katia Ricci1, Eleonora Gentile2, Rosa Gemma Viterbo1, Silvia Giovanna Quitadamo1, Marina de Tommaso1, Maria Trojano1.
Abstract
Cognitive impairment (CI) is a common and disabling symptom of Multiple Sclerosis (MS) with a negative impact on daily living. In this pilot study, we applied magnetoencephalography (MEG) and high density (hd) electroencephalography (EEG) study to evaluate acoustic P300 features in a cohort of early MS. Sixteen MS patients (pwMS) and 19 healthy controls (HCs) matched for age and gender underwent an MEG-/(hd)-EEG-co-recording, using 306-channel Vectorview and 64 scalp electrodes. CI was assessed using Rao's Brief Repeatable Battery (BRB). Moreover, we performed psychometric tests to assess depression and fatigue. In pwMS, we observed a slight latency prolongation of P300 peak compared to HCs, while P300 amplitude and scalp distribution were similar in the two groups. pwMS did not show an amplitude reduction and different scalp distribution of Event-Related Potentials (ERPs) and Event Related Fields (ERFs) related to an acoustic oddball paradigm. We found an inverse correlation between P300 amplitude and fatigue (r Spearman = -0.4; p = 0.019). In pwMS, phenomena of cortical adaptation to early dysfunction could preserve the cognitive performance of the P300 acoustic task, while the development of fatigue could prospectively lead to amplitude decline of P300, suggesting its possible role as a biomarker.Entities:
Keywords: EEG; MEG; cognitive impairment; early stage; event related potentials; fatigue; multiple sclerosis
Year: 2021 PMID: 33918861 PMCID: PMC8069556 DOI: 10.3390/brainsci11040481
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Demographic and clinical variables of participant groups.
| Patient ( | Controls ( | ||
|---|---|---|---|
| Sex, | |||
| F | 14 (87.50%) | 13 (68.42%) | 0.19 × |
| M | 2 (12.50%) | 6 (31.58%) | |
| Age (years) * | 36.5 ± 7.5 | 36.0 ± 16.0 | 0.98 ° |
| Education (years) * | 13 ± 1 | 13 ± 4 | 0.49 ° |
| Duration of disease (months) * | 11.44 ± 19.96 | ||
| EDSS * | 2.0 ± 1 | ||
| Clinical phenotype | |||
| CIS, | 1 (6.25%) | ||
| RRMS, | 15 (93.75%) |
× = Chi square value; ° = ANOVA F values; n°, number; *, median ± interquartile range; EDSS, Expanded Disability Status Scale; CIS, Clinically isolated syndrome; RRMS, relapsing-remitting multiple sclerosis.
Mean values and statistical analysis of cognitive tests, fatigue severity scale inventory (FSS), and Beck Depression Inventory (BDI) between 16 pwMS and 19 HCs.
| Mean | Error DS | 95% CI | ANOVA | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| PASAT | |||||
| Control | 140.000 | 9.162 | 121.338 | 158.662 | F 5.21 |
| Patient | 109.500 | 9.717 | 89.706 | 129.294 | P 0.029 |
| SDMT | |||||
| Control | 52.611 | 3.303 | 45.884 | 59.339 | F 1.32 |
| Patient | 47.063 | 3.503 | 39.927 | 54.198 | P 0.25 |
| FSS | |||||
| Control | 1.139 | 0.408 | 0.308 | 1.970 | F 6.29 |
| Patient | 2.631 | 0.433 | 1.750 | 3.513 | P 0.017 |
| BDI | |||||
| Control | 2.72 | 1.13 | 0.4 | 5.04 | F 4.51 |
| Patient | 6.25 | 1.21 | 3.79 | 8.71 | P 0.041 |
PASAT, Paced Auditory Serial Addition Tests; SDMT, Symbol Digit Modality Test.
Differences in global cognitive domain scores between Multiple Sclerosis patients (pwMS) and healthy controls (HCs).
| pw | HCs | ||
|---|---|---|---|
| Attention and processing speed | 121 | 157 | |
| Memory | 105 | 122 | |
| Verbal Fluency | 19 | 23 | |
| Executive Functions | 122 | 83 |
Mean values and standard deviation of P300 amplitude and latency measured on Pz electrode. Results of one-way ANOVA are reported.
| Patients ( | Controls ( | ANOVA: F | ||
|---|---|---|---|---|
| P300 latency (msec) | 326.15 ± 28.85 | 311.37 ± 31.3 | 1.66 | 0.21 |
| P300 amplitude (uV) | 5.7 ± 4 | 6.7 ± 3.4 | 0.61 | 0.4 |
Figure 1Grand Average of P300 in 19 HCs (blue trace) and 16 pwMs (red trace). Values are represented in uV.
Figure 2Topographical representation of Grand Average of P300 peak in 16 pwMS (above) and 19 HCs (below).
Figure 3Standard trial. Representative parietal midline gradiometer (a,b), magnetometer (c,d) and electroencephalography (EEG) derivation (e,f) for HCs (top) and pwMS (bottom).
Figure 4Topographical (and temporal, top left inset) distribution of the significant cluster (for (a) gradiometer, p = 0.049; (b) magnetometer p = 0.04).